MindOb: A 12-month Computerized Mindfulness-based Intervention for Obese Individuals

Study of the Effects of Mindfulness on Impulsive Eating, Motivation Toward Exercise, and Weight Loss in Obese Patients: Randomized Controlled Trial

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02571387

Acronym

MindOb

Enrollment

Registered

2015-10-08

Start date

2016-05-31

Completion date

2019-10-31

Last updated

2018-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge-Eating Disorder, Obesity

Keywords

Motivation, Impulsive eating, Mindfulness, Self-help, Physical activity, Weight-loss

Brief summary

The purpose of this study is to evaluate the efficacy of a daily 12-month computerized mindfulness-based intervention in obese patients diagnosed with Binge Eating Disorder (BED) on: impulsive eating, motivation toward exercise, and weight loss.

Interventions

BEHAVIORALMindfulness-based intervention

BEHAVIORALSham meditation

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Adult aged between 18 and 65 years * Obese (BMI \>= 30) * Recruited from the nutrition pole of Ambroise Paré Hospital * Diagnosed with Binge-Eating Disorder (BED) according to DSM5 criteria * Informed consent provided during inclusion interview

Exclusion criteria

* Already participating in a clinical trial * Bariatric surgery patients (except for gastric band removed at least 3 years before) * Planned bariatric surgery * Central obese (genetic) * Pregnant women * No internet access at home * Difficulties to understand French language * Patients under social protection * Cognitive dysfunctions in understanding simple guidelines provided by the paramedical staff (e.g., diet or exercise guidelines) * Auditory disorders not allowing to hear audio files * Blurred vision not allowing to use Internet

Design outcomes

Primary

Measure	Time frame
Change in impulsive eating (TFEQ-R18 uncontrolled eating subscale)	From baseline to study completion (12 months). Assessments at baseline, 1 month, 6 months and 12 months.

Secondary

Measure	Time frame	Description
Change in motivational regulation toward exercise (BREQ-II)	From baseline to study completion (12 months). Assessments at baseline, 1 month, 6 months and 12 months.	Behavioral Regulation in Exercise Questionnaire-II (5 subscales): amotivation, external regulation, introjected regulation, identified regulation, intrinsic regulation
Change in self-reported physical activity (IPAQ)	From baseline to study completion (12 months). Assessments at baseline, 1 month, 6 months and 12 months.	International Physical Activity Questionnaire short form
Change in pedometers-measured physical activity	From baseline to study completion (12 months). Assessments at baseline, 6 months and 12 months.	Pedometers on a daily basis for 7 days (ref: ONWalk100)
Change in self-reported anxiety and depression (HADS)	From baseline to study completion (12 months). Assessments at baseline, 1 month, 6 months and 12 months.	Hospital Anxiety and Depression Scale (2 subscales): anxiety and depression
Change in daily mindful responding (DMRS)	From baseline to study completion (12 months). Assessments at baseline, 6 months and 12 months.	Daily Mindful Responding Scale on a daily basis for 7 days (at baseline, 6 months and 12 months)
Change in plasma concentration of leptin, adiponection and BDNF	From baseline to study completion (12 months). Assessments at baseline, 6 months and 12 months.	—
Change in body mass index (kg/m2)	From baseline to study completion (12 months). Assessments at baseline, 6 months and 12 months.	BMI as measured by a physician
Change in food intake	From baseline to study completion (12 months). Assessments at baseline, 6 months and 12 months.	Dietary survey on a daily basis for 7 days (at baseline, 6 months and 12 months)
Change in mindfulness skills (MAAS, AAQ-II)	From baseline to study completion (12 months). Assessments at baseline, 1 month, 6 months and 12 months.	Combination of scores in Mindful Attention Awareness Scale; Acceptance and Action Questionnaire-II

Other

Measure	Time frame
Compliance to the intervention (number of sessions done divided by number of session due)	From baseline to study completion (12 months). Assessments at baseline, 1 month, 6 months and 12 months.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026